Table 2.
Characteristics | Overall survival | |||||
---|---|---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||||
HR | 95% CI | P value | HR | 95% CI | P value | |
CCDC45 expression | 14.635 | (4.424-48.412) | <0.001 | 11.413 | (3.402-38.285) | <0.001 |
Low vs. high | ||||||
Age (years) | 1.318 | (0.352-1.476) | 0.371 | |||
≤50 vs. >50 | ||||||
Gender | 0.536 | (0.128-2.249) | 0.394 | |||
Male vs. female | ||||||
AJCC stage | 2.469 | (1.197-5.092) | 0.014 | 1.655 | (0.790-3.466) | 0.182 |
I vs. II-III | ||||||
HBsAg | 0.692 | (0.265-1.806) | 0.452 | |||
Negative vs. positive | ||||||
AFP (ng/ml) | 1.182 | (0.574-2.436) | 0.650 | |||
≤ 400 vs. >400 | ||||||
Total bilirubin (μmol/L) | 0.930 | (0.357-2.424) | 0.882 | |||
≤20 vs. >20 | ||||||
ALT (U/L) | 0.867 | (0.408-1.812) | 0.711 | |||
≤ 45 vs. >45 | ||||||
GGT (U/L) | 0.401 | (0.164-0.977) | 0.044 | 0.470 | (0.184-1.203) | 0.115 |
≤ 40 vs. >40 | ||||||
Edmondson-Steiner grade | 4.985 | (2.274-10.928) | < 0.001 | 3.335 | (1.497-7.428) | 0.003 |
I-II vs. III-IV | ||||||
Tumor number | 1.887 | (0.771-4.621) | 0.165 | |||
Single vs. multiple | ||||||
Tumor size (cm) | 2.103 | (1.033-4.281) | 0.041 | 1.183 | (0.560-2.502) | 0.660 |
≤ 5 vs. >5 |